ArticleAmerican journal of translational research2020

Metronomic paclitaxel improves the efficacy of PD-1 monoclonal antibodies in breast cancer by transforming the tumor immune microenvironment.

Qian Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.